Insurance interference in electrophysiology: Reclaiming control for timely cardiac care

Prior authorization (PA)-originally intended to curb unindicated treatments-has become a pervasive hurdle that often delays or denies timely care. Third-party (TP) insurance companies have weaponized the PA process to stall access. Complex algorithms and Third-party (TP) insurance payer rule books-often ignoring guidelines from medical societies-systematically restrict patient access to appropriate care. The burden of navigating this complex system falls on providers with limited influence and resources. In electrophysiology (EP), where timely intervention is critical, these barriers can have serious consequences. This article examines how PA impedes essential EP therapies (including left atrial appendage occlusion, cardiac implantable electronic device implants, and antiarrhythmic or anticoagulant medications) and how delays affect outcomes, workflow, and health equity. We also investigate the root causes of the PA problem and explore policy solutions to streamline access to needed care.